XERS - Company ID 0001867096
Xeris Biopharma Holdings, Inc. has filed 290 public company documents between 2021 and 2026. The most frequent type is insider trade (129 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 3 | New insider ownership | 1y ago2025-03-07 | 2025-02-25 | View filing |
| S-8 | Employee stock plan | 1y ago2025-03-06 | - | View filing |
| S-3 | Securities registration | 1y ago2025-03-06 | - | View filing |
| 10-K | Annual report | 1y ago2025-03-06 | 2024-12-31 | View filing |
| 8-K | Major company event | 1y ago2025-03-06 | 2025-03-06 | View filing |
| 8-K | Major company event | 1y ago2025-02-24 | 2025-02-24 | View filing |
| 4 | Insider trade | 1y ago2025-02-03 | 2025-01-31 | View filing |
| 4 | Insider trade | 1y ago2025-02-03 | 2025-01-31 | View filing |
| 4 | Insider trade | 1y ago2025-02-03 | 2025-01-31 | View filing |
| 4 | Insider trade | 1y ago2025-02-03 | 2025-01-31 | View filing |
| 4 | Insider trade | 1y ago2025-02-03 | 2025-01-31 | View filing |
| 8-K | Major company event | 1y ago2025-01-10 | 2025-01-10 | View filing |
| 4 | Insider trade | 1y ago2025-01-07 | 2025-01-03 | View filing |
| 4 | Insider trade | 1y ago2025-01-07 | 2025-01-03 | View filing |
| 4 | Insider trade | 1y ago2025-01-07 | 2025-01-03 | View filing |
| 4 | Insider trade | 1y ago2025-01-07 | 2025-01-03 | View filing |
| 4 | Insider trade | 1y ago2025-01-07 | 2025-01-03 | View filing |